Patent · US Active

Interaction control of cationic biocides using labile anionic polyelectrolytes

US9040510B2 · kind B2 · utility

0Cited by
19References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 25, 2009
Grant dateMay 26, 2015
Priority date
Expiry dateOct 25, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L12/145
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Methods of inhibiting the uptake of cationic biocides into medical devices such as contact lenses and implants are described. Methods of stabilizing emulsions containing cationic biocides are also described. In particular, the present invention provides for the use of polymers acting as labile anionic polyelectrolytes to reversibly bind cationic biocides. The reversible binding can reduce the deleterious effects of cationic biocides while maintaining biocidal activity. Preferred polymers include galactomannan and polyvinyl alcohol.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.